BeStock  
Markets › Compare › KURA vs ATTO

KURA vs ATTO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
KURA · Kura Oncology$6.91 ▼ 5.99%
ATTO · Attovia Therapeutics$15.10 ▼ 3.08%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5881105129153Aug 5, '26Sep 29, '26Nov 20, '26
  • KURA -24.9%
  • ATTO -31.1%

Head to head

MetricKURAATTO
Price$6.91$15.10
Change today▼ 5.99%▼ 3.08%
Market cap$634.88M$690.26M
Return, 3 months-44.3%-26.8%
Return, year to date-33.5%–
Return, 1 year-38.1%–
P/E (TTM)––
P/B35.41.7
P/E percentile vs own 5y99th94th
Dividend yield––
Revenue growth (YoY, latest qtr)+10.1%-100.0%
Net profit growth (YoY)+5.3%-61.6%
Gross margin98.8%–
Operating margin-394.3%-5,945.5%
Net margin-369.3%-5,477.2%
Return on equity-224.9%-19.8%
Analyst target vs. price+307.2%+171.5%
Analyst buy share100%100%
RSI (14)3345
30-day volatility104.3%62.6%
Max drawdown, 1 year-50.0%-46.3%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ATTO is the largest of the group by market value.
  • KURA is growing revenue fastest.
  • KURA keeps the most profit per dollar of sales.
  • ATTO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top